Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP vs QLB2 for Postoperative Analgesia in Inguinal Hernia Repair
NCT03126084Phase 4Completed
- Sponsor
- Bozyaka Training and Research Hospital
- Start
- May 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms), sponsored by Bozyaka Training and Research Hospital. Primary endpoint: Pain Intensity at 48 hours. Started May 2017; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03126084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03126084.